Stock Ratings | Canaccord raised its target price for Cardiol Therapeutics (CRDL) to $10, representing a potential upside of 455.56%; while Barclays lowered its target price for Occidental Petroleum (OXY) to $71.
Cardiol Therapeutics Inc. Class A CRDL | 0.00 | |
MacroGenics, Inc. MGNX | 0.00 | |
Alpha Cognition Inc ACOG | 0.00 | |
IMMUNIC INC IMUX | 0.00 | |
Codexis, Inc. CDXS | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Canaccord Genuity: Maintaining a "buy" rating on Cardiol Therapeutics ( Cardiol Therapeutics Inc. Class A(CRDL.US) ), while raising the price target from $8 to $10.
B. Riley Securities: Maintaining a "buy" rating on Macrogenics ( MacroGenics, Inc.(MGNX.US) ), while raising the price target from $9 to $11.
HC Wainwright & Co.: Maintaining a "buy" rating on Alpha Cognition ( Alpha Cognition Inc(ACOG.US) ), while raising the price target from $18 to $20.
Wedbush: Initial rating for IMMUNIC IMMUNIC INC(IMUX.US) ) stock at "outperform," with a price target of $45.
Piper Sandler: Maintaining an "overweight" rating on Codexis ( Codexis, Inc.(CDXS.US) ), while lowering the price target from $9 to $8.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Cardiol Therapeutics Inc. Class A(CRDL.US) | to lift | $10.0 | $1.8 | 455.56% | Canaccord Genuity |
| MacroGenics, Inc.(MGNX.US) | to lift | $11.0 | $4.06 | 170.94% | B. Riley Securities |
| Alpha Cognition Inc(ACOG.US) | to lift | $20.0 | $8.84 | 126.24% | HC Wainwright & Co. |
| Celcuity Inc.(CELC.US) | to lift | $175.0 | $92.44 | 89.31% | Jefferies |
| CAE Inc.(CAE.US) | to lift | $46.0 | $27.14 | 69.49% | RBC Capital |
| IMMUNIC INC(IMUX.US) | Initial classification | $45.0 | $16.03 | 180.72% | Wedbush |
| Codexis, Inc.(CDXS.US) | cut | $8.0 | $1.59 | 403.14% | Piper Sandler |
| ADC Therapeutics Ltd(ADCT.US) | cut | $5.0 | $1.1 | 354.55% | Jefferies |
| Nyxoah SA(NYXH.US) | cut | $6.0 | $1.6 | 275.0% | Cantor Fitzgerald |
| Ardelyx, Inc.(ARDX.US) | cut | $15.0 | $4.06 | 269.46% | Piper Sandler |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Wells Fargo: Maintaining an "overweight" rating on CrowdStrike Holdings CrowdStrike(CRWD.US) , while raising its price target from $181.25 to $230.
Wells Fargo: Maintaining an "overweight" rating on Palo Alto Networks ( Palo Alto Networks, Inc.(PANW.US) ), while raising its price target from $420 to $475.
Piper Sandler: Maintaining a "neutral" rating on PayPal Holdings ( PayPal Holdings, Inc.(PYPL.US) ), while raising the price target from $42 to $59.
Needham: Maintaining a "buy" rating on WhiteFiber ( WhiteFiber(WYFI.US) ), while raising the price target from $38 to $41.
First Coverage
Piper Sandler: Initial rating for Dave ( Dave, Inc. Class A(DAVE.US) ) stock at "overweight", with a price target of $390.
Jefferies: Initial rating for Freenome ( Freenome, Inc.(FRNM.US) ) stock at "Buy", with a target price of $17.
Citigroup: Initial rating for Federal Signal ( Federal Signal Corporation(FSS.US) ) stock at "buy", with a target price of $150.
Wells Fargo: Huntington Bancshares Incorporated(HBAN.US) stock has an initial rating of "overweight", with a price target of $23.
reduction
Cantor Fitzgerald: Maintaining an "overweight" rating on CVRx ( CVRx, Inc.(CVRX.US) ), while lowering the price target from $13 to $5.
Mizuho: Maintaining its "outperform" rating for Intuit ( Intuit Inc.(INTU.US) ) stock, while lowering its price target from $500 to $430.
Barclays: Maintaining an "overweight" rating on Occidental Petroleum Occidental Petroleum Corporation(OXY.US) ), while lowering its price target from $75 to $71.
Guggenheim: Maintaining a "buy" rating on Walmart ( Walmart Inc.(WMT.US) ) stock, while lowering the price target from $137 to $135.
Barclays: Maintaining an "overweight" rating on ExxonMobil Exxonmobil Holdings Corporation(XOM.US) stock, while lowering its price target from $182 to $177.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.